OBJECTIVE: To investigate the relationships between 2 anesthetic techniques, or the extent of allodynia around the surgical wound, and the occurrence of chronic post-thoracotomy pain. DESIGN: Prospective, randomized study. SETTING: A single-institution, university hospital. PARTICIPANTS: Thirty-eight patients who underwent elective thoracotomy under general anesthesia. INTERVENTIONS: High-dose remifentanil (average effect-site concentration 5.61 +/- 0.84 ng/mL) with epidural analgesia started and at the end of surgery or low-dose remifentanil (average effect site concentration 1.99 +/- 0.02 ng/mL) with epidural analgesia with 0.5% ropivacaine started at the beginning of anesthesia. MEASUREMENTS AND MAIN RESULTS:Pain intensity and the extent of allodynia around the wound were measured during the hospital stay. The presence and intensity of residual pain were assessed 1, 3, and 6 months after surgery and at the end of the study (6-13 months, average 9 months). A DN4 neuropathic pain diagnostic questionnaire was conducted at the same times. In the high-dose group, the area with allodynia was three times larger than the area in the low-dose group. The increased allodynia was associated with a higher incidence of chronic pain (RR: 2.7-4.2) 3 and 6 months after surgery and at the end of the study (median follow-up: 9.5 months). CONCLUSIONS: High-dose remifentanil (0.14-0.26 microg/kg/min) without epidural analgesia during surgery is associated with a large area of allodynia around the wound. These patients develop a much higher incidence of chronic pain than those receiving low-dose remifentanil with epidural analgesia during surgery. Copyright 2010 Elsevier Inc. All rights reserved.
RCT Entities:
OBJECTIVE: To investigate the relationships between 2 anesthetic techniques, or the extent of allodynia around the surgical wound, and the occurrence of chronic post-thoracotomy pain. DESIGN: Prospective, randomized study. SETTING: A single-institution, university hospital. PARTICIPANTS: Thirty-eight patients who underwent elective thoracotomy under general anesthesia. INTERVENTIONS: High-dose remifentanil (average effect-site concentration 5.61 +/- 0.84 ng/mL) with epidural analgesia started and at the end of surgery or low-dose remifentanil (average effect site concentration 1.99 +/- 0.02 ng/mL) with epidural analgesia with 0.5% ropivacaine started at the beginning of anesthesia. MEASUREMENTS AND MAIN RESULTS:Pain intensity and the extent of allodynia around the wound were measured during the hospital stay. The presence and intensity of residual pain were assessed 1, 3, and 6 months after surgery and at the end of the study (6-13 months, average 9 months). A DN4neuropathic pain diagnostic questionnaire was conducted at the same times. In the high-dose group, the area with allodynia was three times larger than the area in the low-dose group. The increased allodynia was associated with a higher incidence of chronic pain (RR: 2.7-4.2) 3 and 6 months after surgery and at the end of the study (median follow-up: 9.5 months). CONCLUSIONS: High-dose remifentanil (0.14-0.26 microg/kg/min) without epidural analgesia during surgery is associated with a large area of allodynia around the wound. These patients develop a much higher incidence of chronic pain than those receiving low-dose remifentanil with epidural analgesia during surgery. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: Peter M Grace; Keith A Strand; Erika L Galer; Daniel J Urban; Xiaohui Wang; Michael V Baratta; Timothy J Fabisiak; Nathan D Anderson; Kejun Cheng; Lisa I Greene; Debra Berkelhammer; Yingning Zhang; Amanda L Ellis; Hang Hubert Yin; Serge Campeau; Kenner C Rice; Bryan L Roth; Steven F Maier; Linda R Watkins Journal: Proc Natl Acad Sci U S A Date: 2016-05-31 Impact factor: 11.205
Authors: James X Wu; Melissa Assel; Andrew Vickers; Anoushka M Afonso; Rebecca S Twersky; Brett A Simon; Marc A Cohen; Elizabeth F Rieth; Jennifer R Cracchiolo Journal: J Surg Oncol Date: 2019-11-03 Impact factor: 3.454
Authors: Lindsay D Nelson; Robyn E Furger; Jana Ranson; Sergey Tarima; Thomas A Hammeke; Christopher Randolph; William B Barr; Kevin Guskiewicz; Christopher M Olsen; E Brooke Lerner; Michael A McCrea Journal: J Neurotrauma Date: 2017-11-17 Impact factor: 5.269
Authors: Amanda Ellis; Peter M Grace; Julie Wieseler; Jacob Favret; Kendra Springer; Bryce Skarda; Monica Ayala; Mark R Hutchinson; Scott Falci; Kenner C Rice; Steven F Maier; Linda R Watkins Journal: Brain Behav Immun Date: 2016-08-09 Impact factor: 7.217